Management of Mild Hyponatremia (Sodium 134 mmol/L)
For asymptomatic mild hyponatremia with sodium 134 mmol/L, adequate solute intake (salt and protein) combined with initial fluid restriction of 500 mL/day adjusted according to sodium levels is the preferred approach; hypertonic saline is contraindicated. 1, 2
Initial Assessment
Check for severe symptoms first: Seizures, coma, abrupt mental status changes, or respiratory distress mandate emergency treatment, but these are absent in mild hyponatremia at this level. 1
Obtain baseline diagnostic workup: Measure serum osmolality, urine osmolality, urine sodium, thyroid function, and cortisol when indicated to determine the underlying cause. 1
Assess volume status: Categorize the patient as hypovolemic, euvolemic, or hypervolemic using clinical examination and point-of-care ultrasonography, as this determines treatment strategy. 3, 4
Conservative Management Strategy
Implement adequate solute intake: Increase dietary salt and protein consumption as first-line therapy for asymptomatic mild hyponatremia. 2, 5
Apply initial fluid restriction: Start with 500 mL/day and adjust based on serial sodium measurements; however, nearly half of SIADH patients do not respond to fluid restriction alone. 2
Avoid hypertonic saline: 3% hypertonic saline is contraindicated for asymptomatic, mild, chronic hyponatremia and should be reserved only for patients with severe symptoms (seizures, coma) or acute hyponatremia with sodium <120 mmol/L. 1
Target Goals and Monitoring
Set appropriate sodium target: A target serum sodium of approximately 131 mmol/L is adequate for most patients with mild chronic hyponatremia, rather than aiming for full normalization. 1
Monitor appropriately: For conservative management, daily sodium monitoring is sufficient once the patient is stable; if active therapy is employed, check sodium every 4–6 hours. 1
Respect correction limits: Serum sodium should not increase by more than 10 mmol/L in any 24-hour period to avoid osmotic demyelination syndrome, and correction rates exceeding 1 mmol/L per hour are prohibited except in severe, acute symptomatic cases. 1
Second-Line Therapy
Consider oral urea for refractory SIADH: If fluid restriction fails in euvolemic hyponatremia (SIADH), oral urea (40 g dissolved in 100–150 mL normal saline every 8 hours) is highly effective and safe. 1, 2, 5
Vaptans as alternative: Tolvaptan may be considered in euvolemic or hypervolemic patients with high ADH activity, though it carries risks of overly rapid correction and increased thirst. 2, 5
Volume-Specific Considerations
Hypovolemic hyponatremia: Treat with normal saline infusions; fluid restriction can precipitate cerebral infarction in hypovolemic states. 1, 3
Hypervolemic hyponatremia: Manage the underlying cause (heart failure, cirrhosis) and implement free water restriction. 3
Clinical Pitfalls to Avoid
Do not pursue rapid normalization: Gradual correction and clinical evaluation is preferable over rapid normalization toward laboratory reference ranges, as even mild chronic hyponatremia is associated with cognitive impairment, gait disturbances, and increased falls and fractures. 2, 5
Identify medication causes: Review for thiazide diuretics, antidepressants, anticonvulsants, antipsychotics, SGLT2 inhibitors, immune checkpoint inhibitors, and other drugs that commonly induce hyponatremia. 6, 7
Assess for endocrine causes: Screen for hypothyroidism and adrenal insufficiency, particularly in patients on immune checkpoint inhibitors where secondary or primary adrenal insufficiency may occur. 6